CheckMyRecalls

Graviti Pharmaceuticals Private Limited recalls Bupropion…

Graviti Pharmaceuticals Private Limited recalls Bupropion Hydrochloride Extended-Release Tablets USP (XL)

Published
29 Oct 2025
Units affected
46,512/30 count bottles
Agency
FDA
Country
United States

The hazard

Failed Tablet/Capsule Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.

Brand / company
Graviti Pharmaceuticals Private Limited
Codes / lots
Batch # BPB124341A, Exp date: 10/2026
Distribution
Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.